Spravato (esketamine) - Ketamine Therapy
How Spravato Treats Depression
SPRAVATO is a nasal spray treatment that targets the brain's glutamate system, offering rapid relief for adults with TRD.
Ketamine services offered in San Diego
Spravato is used to treat depression in adults when other therapies have been ineffective. While SPRAVATO is derived from ketamine, it's specifically the esketamine form, which is approved by the FDA for treating depression. Some people refer to SPRAVATO as ketamine due to their chemical similarity, but esketamine is more targeted in its effects, making it a safer and more controlled options for patients with treatment resistant depression.
Spravato acts as a ketamine agent that is easily dispensed intranasally under the careful supervision of a provider. It has a different mode of action than traditional anti-depressant medications, and can reduce symptoms of depression within hours to days, making it an option for those needing rapid relief. Spravato works on Glutamate, a neuro-chemical which has profound response in mood regulation in the brain and which promotes neuron and nerve receptor growth thus enabling brain to recoup and strengthen itself.
Spravato offers a different approach to depression.
Response Rate
69%
69.3 percent of patients who completed 4 weeks of SPRAVATO therapy responded to treatment.
Remission Rate
53%
52.5 percent of patients after completing 4 weeks of SPRAVATO treatment achieved remission of their depression.
What is Spravato®?
Spravato (esketamine) is a prescription nasal spray that is used to treat adults with treatment-resistant depression (TRD). Spravato is an FDA approved therapy only when taken in conjunction with an oral antidepressant.
FDA Approved
For adults struggling with
treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or actions.
Sustainable Relief
About 70% of patients show a clinically meaningful response, with treatments easily integrated into your life.
Insurance Coverage
Spravato is covered by several major insurance payers, making it an accessible option for many if you've tried antidepressants and therapy.
Spravato® is taken at a Certified Treatment Center.
Three Treatment Phases
Induction: Twice a week for the first four weeks
Optimization: Once a week for the following four weeks
Maintenance: Weekly or Bi-weekly Treatments for up to 12 months
Treatment Protocol
Must be taken with an oral antidepressant
Avoid eating 2 hours before, and drinking liquids 30 minutes before treatment
Following administration, you will be observed for 2 hours by your provider
Patient cannot drive from their appointment on treatment days due to side effects, find your ride!
Covered by Major Insurance Companies
Business Hours
Mon: 7am - 7pm
Tues: 7am - 7pm
Wed: 7am - 7pm
Thurs: 7am - 7pm
Fri: 7am - 7pm
Sat/Sun: Closed
